Provided by Tiger Trade Technology Pte. Ltd.

NEUROONE MEDICAL TECH

3.69
-0.2100-5.38%
Post-market: 3.60-0.0900-2.44%17:27 EDT
Volume:55.55K
Turnover:211.69K
Market Cap:31.81M
PE:-4.63
High:4.03
Open:3.95
Low:3.63
Close:3.90
52wk High:6.96
52wk Low:3.27
Shares:8.62M
Float Shares:7.27M
Volume Ratio:1.75
T/O Rate:0.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7968
EPS(LYR):-0.5387
ROE:-204.44%
ROA:-71.68%
PB:5.92
PE(LYR):-6.85

Loading ...

Neuroone Medical Technologies Corp - Restatement Corrects $0.5 Mln Revenue Overstatement for Q1 2026 - SEC Filing

THOMSON REUTERS
·
May 23

NeuroOne restates March-quarter results after $0.5 million revenue overstatement

Reuters
·
May 23

NeuroOne Medical Tech Is Maintained at Buy by Ladenburg Thalmann

Dow Jones
·
May 14

Analysts Offer Insights on Healthcare Companies: DarioHealth (DRIO), NeuroOne Medical Technologies (NMTC) and COMPASS Pathways (CMPS)

TIPRANKS
·
May 14

NeuroOne Medical Tech Q2 EPS $(0.25) Misses $(0.23) Estimate, Sales $2.391M Miss $2.576M Estimate

Benzinga
·
May 12

NeuroOne Medical Technologies Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

NeuroOne FY26 Q2 net loss narrows to $2.1 million; product revenue rises 72% to $2.4 million

Reuters
·
May 12

NeuroOne Medical Technologies Corp expected to post a loss of 23 cents a share - Earnings Preview

Reuters
·
May 08

NeuroOne regains Nasdaq compliance after shares hold above $1 bid price

Reuters
·
May 04

NeuroOne COO Christopher Volker to become CFO as McClurg retires

Reuters
·
Apr 30

Neuroone Medical Technologies Corp - Ronald Mcclurg to Retire as CFO Effective June 30, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 30

U.S. RESEARCH ROUNDUP-Coca-Cola Co, Mondelez, Zeta Global Holdings

Reuters
·
Apr 29

Neuroone Medical Technologies Corp : Jonestrading Adjusts Target Price to $8 From $1.5 to Reflect 1-for-6 Reverse Stock Split

THOMSON REUTERS
·
Apr 29

NeuroOne Medical Technologies trading halted, news pending

TIPRANKS
·
Apr 16

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM

Reuters
·
Apr 16

Neuroone Medical Technologies Corp - Approves 1-for-6 Reverse Stock Split Effective April 15, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 14

NeuroOne shareholders approved reverse stock split amendment, elected two directors

Reuters
·
Apr 04

NeuroOne Business Development Director Mark Christianson sells USD 0.01 million common shares

Reuters
·
Apr 02

NeuroOne Business Development Director Mark Christianson Disposes of USD 734 in Common Shares

Reuters
·
Mar 17

Boston Scientific Corp Stock Moved Down by 3.32% on Mar 3: Facts Behind the Movement

TradingKey
·
Mar 04